Lymphoma (relative) risk increases with IBD drugs

Thiopurines and anti-TNF therapy appear to be associated with a small but significantly increased risk of lymphoma in patients with IBD. A French study identified 336 lymphoma cases in more than 189,000 patients with IBD followed for a median of seven years. Patients not exposed to either drug had an incidence rate of lymphoma of ...

Already a member?

Login to keep reading.

© 2021 the limbic